NCT00698191 - Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2012

Conditions

Refractory Systemic Lupus Erythematosus

Interventions

BIOLOGICAL

Allogeneic MSC (AlloMSC)

"Intervention:~Cyclophosphamide will be administered intravenously at at total dose of 0.8-1.8g 24 hours before transplantation.~Allogeneic bone marrow derived mesenchymal stem cells (matched family donors)will be infused intravenously at 106 cells/kg body weight"

Trial Locations (1)

210008

RECRUITING

Department of Rheumatology and Immunology, Nanjing University Medical College Affiliated Drum Tower Hospital, Nanjing